Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05688670 · ClinicalTrials.gov registry record · Phase 4
Regional Anesthesia Following Pediatric Cardiac Surgery
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 52
- Enrollment target
NCT05688670 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 52 participants.
The verdict
NCT05688670, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate pain control following pediatric cardiac surgery with the use of local anesthesia via an ultrasound guided regional anesthetic technique compared with surgeon delivered wound infiltration.
Interventions
- DRUG Ropivacaine 0.2% Injectable Solution
- PROCEDURE Regional Anesthesia
- PROCEDURE Wound infiltration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2025-01-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05688670
The ClinicalTrials.gov registry entry for NCT05688670 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ropivacaine 0.2% Injectable Solution is the first listed.
NCT05688670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05688670 about?
NCT05688670 is a clinical study titled "Regional Anesthesia Following Pediatric Cardiac Surgery". The purpose of this study is to evaluate pain control following pediatric cardiac surgery with the use of local anesthesia via an ultrasound guided regional anesthetic technique compared with surgeon delivered wound infiltration.
What is the current status of trial NCT05688670?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 52 participants. The study started on 2023-03-29. Estimated completion is 2025-01-22.
What interventions are being tested in trial NCT05688670?
The interventions under investigation include: Ropivacaine 0.2% Injectable Solution (DRUG), Regional Anesthesia (PROCEDURE), Wound infiltration (PROCEDURE).
Who is sponsoring clinical trial NCT05688670?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.